Growth Metrics

Merck (MRK) EBIT Margin Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -4,546.00
Dec 31, 2025 5,619.00
Sep 30, 2025 1,954.00
Jun 30, 2025 919.00
Mar 31, 2025 1,163.00
Dec 31, 2024 7,630.00
Sep 30, 2024 1,331.00
Jun 30, 2024 1,524.00
Mar 31, 2024 1,336.00
Dec 31, 2023 -3,450.00
Sep 30, 2023 1,733.00
Jun 30, 2023 -4,953.00
Mar 31, 2023 1,642.00
Dec 31, 2022 1,230.00
Sep 30, 2022 2,775.00
Jun 30, 2022 867.00
Mar 31, 2022 782.00
Dec 31, 2021 4,798.00
Sep 30, 2021 1,876.00
Jun 30, 2021 890.00
Mar 31, 2021 1,892.00
Dec 31, 2020 -3,948.00
Sep 30, 2020 1,073.00
Jun 30, 2020 3,005.00
Mar 31, 2020 2,758.00
Dec 31, 2019 -15,103.00
Sep 30, 2019 1,263.00
Jun 30, 2019 2,625.00
Mar 31, 2019 1,779.00
Dec 31, 2018 2,365.00
Sep 30, 2018 1,454.00
Jun 30, 2018 1,488.00
Mar 31, 2018 425.00
Dec 31, 2017 912.00
Sep 30, 2017 -1,339.00
Jun 30, 2017 481.00
Mar 31, 2017 195.00
Dec 31, 2016 -2,661.00
Sep 30, 2016 1,168.00
Jun 30, 2016 43.00
Mar 31, 2016 -80.00
Dec 31, 2015 1,281.00
Sep 30, 2015 1,965.00
Jun 30, 2015 -96.00
Mar 31, 2015 -2,886.00
Dec 31, 2014 9,400.00
Sep 30, 2014 -5,229.00
Jun 30, 2014 -5,091.00
Mar 31, 2014 -3,864.00